-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U3YchS/yTRii9VbdefPSYxo2YFfL2j9l3yq5E7g5p98pRIKPtKZkbPdQbDDFpmNp 7aB0urjNxjCNkeqv7PvSqg== 0001209191-10-036694.txt : 20100701 0001209191-10-036694.hdr.sgml : 20100701 20100701195804 ACCESSION NUMBER: 0001209191-10-036694 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100701 DATE AS OF CHANGE: 20100701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bay City Capital Fund V, L.P. CENTRAL INDEX KEY: 0001401826 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 10932274 BUSINESS ADDRESS: STREET 1: 750 Battery Street STREET 2: Suite 400 CITY: San Francisco STATE: CA ZIP: 94111 MAIL ADDRESS: STREET 1: 750 Battery Street STREET 2: Suite 400 CITY: San Francisco STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAY CITY CAPITAL LLC CENTRAL INDEX KEY: 0001288452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 10932276 BUSINESS ADDRESS: STREET 1: 750 BATTERY STREET STE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4156763830 MAIL ADDRESS: STREET 1: 750 BATTERY STREET STE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 FORMER NAME: FORMER CONFORMED NAME: BAY CITY CAPITAL FUND LLC DATE OF NAME CHANGE: 20040423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bay City Capital Fund V Co-Investment Fund LP CENTRAL INDEX KEY: 0001409813 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 10932273 BUSINESS ADDRESS: STREET 1: 750 Vattery Street STREET 2: Suite 400 CITY: San Francisco STATE: CA ZIP: 94111 BUSINESS PHONE: (415) 676-3830 MAIL ADDRESS: STREET 1: 750 Vattery Street STREET 2: Suite 400 CITY: San Francisco STATE: CA ZIP: 94111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bay City Capital Management V LLC CENTRAL INDEX KEY: 0001461543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 10932275 BUSINESS ADDRESS: STREET 1: 750 BATTERY STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-676-3830 MAIL ADDRESS: STREET 1: 750 BATTERY STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 4 1 c03103_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2010-06-30 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001288452 BAY CITY CAPITAL LLC 750 BATTERY STREET SUITE 400 SAN FRANCISCO CA 94111 0 0 1 0 0001461543 Bay City Capital Management V LLC 750 BATTERY STREET SUITE 400 SAN FRANCISCO CA 94111 0 0 1 0 0001401826 Bay City Capital Fund V, L.P. 750 BATTERY STREET SUITE 400 SAN FRANCISCO CA 94111 0 0 1 0 0001409813 Bay City Capital Fund V Co-Investment Fund LP 750 BATTERY STREET SUITE 400 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2010-06-30 4 C 0 9808090 A 9808090 D Common Stock 2010-06-30 4 P 0 23378934 0.275 A 33187024 D Common Stock 2010-06-30 4 C 0 186900 A 186900 D Common Stock 2010-06-30 4 P 0 445516 0.275 A 632416 D Common Stock 9091 D Series A Preferred Stock 0.00 2010-06-30 4 C 0 980809 2.20 D 2010-06-30 Common Stock 9808090 0 D Series A Preferred Stock 0.00 2010-06-30 4 C 0 18690 2.20 D 2010-06-30 Common Stock 186900 0 D Each one (1) share of Series A Preferred Stock was converted into ten (10) shares of Common Stock upon the Issuer's common equity closing (as defined in the applicable Certificate of Designation). Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. Represent securities held by Fund V, including indirect interests of BCC and Management V. BCC and Management V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein. Represent securities held by Co-Investment V, including indirect interests of BCC and Management V. BCC and Management V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein. BCC is the sole owner of these shares. Not applicable. Signed by Fred Craves, Managing Director of BCC for itself, for and on behalf of Management V in its capacity as manager thereof, and for and on behalf of Fund V and Co-Investment V in its capacity as manager of Management V, the general partner of Fund V and Co-Investment V. /s/ Fred Craves 2010-07-01 -----END PRIVACY-ENHANCED MESSAGE-----